Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use

M. P. Carrieri, J. P. Moatti, D. Vlahov, Y. Obadia, C. Reynaud-Maurupt, M. Chesney

    Research output: Contribution to journalArticle

    Abstract

    Study objective - To determine the influence of continued drug use and its perception by prescribing physicians on access to antiretroviral treatment among French HIV infected injection drug users (IDUs). Design - Cross sectional including enrolment data (October 1995-1996) of the cohort study MANIF 2000. Access to treatment is compared in three groups: former IDUs (n = 68) and active IDUs whether or not this behaviour remains undetected (n = 38) or detected (n = 17) by physicians. Setting - Hospital departments for specialist AIDS care in south eastern France and inner suburbs of Paris. Patients - All enroled patients with CD4+ cell counts <400 with detailed clinical history, access to treatment, risk behaviours, and past drug use as reported by both physicians and patients (n = 123). Main results - A minority (43.9%) already received an antiretroviral treatment. Active IDUs had worst socioeconomic and psychological conditions but only those detected by physicians were considered as poorly compliant. Logistic regression showed that, with respect to ex-IDUs and independently of clinical stage, active IDUs, whether or not they were perceived as such by physicians, were threefold more likely not to receive antiretroviral treatment. Conclusions - Even among French HIV infected IDUs who have regular access to AIDS specialised hospital care, continued drug use reduced the likelihood of being prescribed antiretroviral treatment. To reduce delays in access to new treatments, specific efforts must be devoted towards both AIDS specialists and IDU patients to overcome current stereotypes of noncompliance associated with continued injection.

    Original languageEnglish (US)
    Pages (from-to)4-8
    Number of pages5
    JournalJournal of Epidemiology and Community Health
    Volume53
    Issue number1
    StatePublished - Jan 1999

    Fingerprint

    Drug Users
    HIV
    Injections
    Pharmaceutical Preparations
    Physicians
    Acquired Immunodeficiency Syndrome
    Therapeutics
    Hospital Departments
    Paris
    CD4 Lymphocyte Count
    Risk-Taking
    France
    Cohort Studies
    Logistic Models
    Psychology

    ASJC Scopus subject areas

    • Public Health, Environmental and Occupational Health

    Cite this

    Carrieri, M. P., Moatti, J. P., Vlahov, D., Obadia, Y., Reynaud-Maurupt, C., & Chesney, M. (1999). Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use. Journal of Epidemiology and Community Health, 53(1), 4-8.

    Access to antiretroviral treatment among French HIV infected injection drug users : The influence of continued drug use. / Carrieri, M. P.; Moatti, J. P.; Vlahov, D.; Obadia, Y.; Reynaud-Maurupt, C.; Chesney, M.

    In: Journal of Epidemiology and Community Health, Vol. 53, No. 1, 01.1999, p. 4-8.

    Research output: Contribution to journalArticle

    Carrieri, MP, Moatti, JP, Vlahov, D, Obadia, Y, Reynaud-Maurupt, C & Chesney, M 1999, 'Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use', Journal of Epidemiology and Community Health, vol. 53, no. 1, pp. 4-8.
    Carrieri, M. P. ; Moatti, J. P. ; Vlahov, D. ; Obadia, Y. ; Reynaud-Maurupt, C. ; Chesney, M. / Access to antiretroviral treatment among French HIV infected injection drug users : The influence of continued drug use. In: Journal of Epidemiology and Community Health. 1999 ; Vol. 53, No. 1. pp. 4-8.
    @article{cbd4bf34527947c1a2d093f3ac3b03b0,
    title = "Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use",
    abstract = "Study objective - To determine the influence of continued drug use and its perception by prescribing physicians on access to antiretroviral treatment among French HIV infected injection drug users (IDUs). Design - Cross sectional including enrolment data (October 1995-1996) of the cohort study MANIF 2000. Access to treatment is compared in three groups: former IDUs (n = 68) and active IDUs whether or not this behaviour remains undetected (n = 38) or detected (n = 17) by physicians. Setting - Hospital departments for specialist AIDS care in south eastern France and inner suburbs of Paris. Patients - All enroled patients with CD4+ cell counts <400 with detailed clinical history, access to treatment, risk behaviours, and past drug use as reported by both physicians and patients (n = 123). Main results - A minority (43.9{\%}) already received an antiretroviral treatment. Active IDUs had worst socioeconomic and psychological conditions but only those detected by physicians were considered as poorly compliant. Logistic regression showed that, with respect to ex-IDUs and independently of clinical stage, active IDUs, whether or not they were perceived as such by physicians, were threefold more likely not to receive antiretroviral treatment. Conclusions - Even among French HIV infected IDUs who have regular access to AIDS specialised hospital care, continued drug use reduced the likelihood of being prescribed antiretroviral treatment. To reduce delays in access to new treatments, specific efforts must be devoted towards both AIDS specialists and IDU patients to overcome current stereotypes of noncompliance associated with continued injection.",
    author = "Carrieri, {M. P.} and Moatti, {J. P.} and D. Vlahov and Y. Obadia and C. Reynaud-Maurupt and M. Chesney",
    year = "1999",
    month = "1",
    language = "English (US)",
    volume = "53",
    pages = "4--8",
    journal = "Journal of Epidemiology and Community Health",
    issn = "0143-005X",
    publisher = "BMJ Publishing Group",
    number = "1",

    }

    TY - JOUR

    T1 - Access to antiretroviral treatment among French HIV infected injection drug users

    T2 - The influence of continued drug use

    AU - Carrieri, M. P.

    AU - Moatti, J. P.

    AU - Vlahov, D.

    AU - Obadia, Y.

    AU - Reynaud-Maurupt, C.

    AU - Chesney, M.

    PY - 1999/1

    Y1 - 1999/1

    N2 - Study objective - To determine the influence of continued drug use and its perception by prescribing physicians on access to antiretroviral treatment among French HIV infected injection drug users (IDUs). Design - Cross sectional including enrolment data (October 1995-1996) of the cohort study MANIF 2000. Access to treatment is compared in three groups: former IDUs (n = 68) and active IDUs whether or not this behaviour remains undetected (n = 38) or detected (n = 17) by physicians. Setting - Hospital departments for specialist AIDS care in south eastern France and inner suburbs of Paris. Patients - All enroled patients with CD4+ cell counts <400 with detailed clinical history, access to treatment, risk behaviours, and past drug use as reported by both physicians and patients (n = 123). Main results - A minority (43.9%) already received an antiretroviral treatment. Active IDUs had worst socioeconomic and psychological conditions but only those detected by physicians were considered as poorly compliant. Logistic regression showed that, with respect to ex-IDUs and independently of clinical stage, active IDUs, whether or not they were perceived as such by physicians, were threefold more likely not to receive antiretroviral treatment. Conclusions - Even among French HIV infected IDUs who have regular access to AIDS specialised hospital care, continued drug use reduced the likelihood of being prescribed antiretroviral treatment. To reduce delays in access to new treatments, specific efforts must be devoted towards both AIDS specialists and IDU patients to overcome current stereotypes of noncompliance associated with continued injection.

    AB - Study objective - To determine the influence of continued drug use and its perception by prescribing physicians on access to antiretroviral treatment among French HIV infected injection drug users (IDUs). Design - Cross sectional including enrolment data (October 1995-1996) of the cohort study MANIF 2000. Access to treatment is compared in three groups: former IDUs (n = 68) and active IDUs whether or not this behaviour remains undetected (n = 38) or detected (n = 17) by physicians. Setting - Hospital departments for specialist AIDS care in south eastern France and inner suburbs of Paris. Patients - All enroled patients with CD4+ cell counts <400 with detailed clinical history, access to treatment, risk behaviours, and past drug use as reported by both physicians and patients (n = 123). Main results - A minority (43.9%) already received an antiretroviral treatment. Active IDUs had worst socioeconomic and psychological conditions but only those detected by physicians were considered as poorly compliant. Logistic regression showed that, with respect to ex-IDUs and independently of clinical stage, active IDUs, whether or not they were perceived as such by physicians, were threefold more likely not to receive antiretroviral treatment. Conclusions - Even among French HIV infected IDUs who have regular access to AIDS specialised hospital care, continued drug use reduced the likelihood of being prescribed antiretroviral treatment. To reduce delays in access to new treatments, specific efforts must be devoted towards both AIDS specialists and IDU patients to overcome current stereotypes of noncompliance associated with continued injection.

    UR - http://www.scopus.com/inward/record.url?scp=0032921608&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0032921608&partnerID=8YFLogxK

    M3 - Article

    C2 - 10326045

    AN - SCOPUS:0032921608

    VL - 53

    SP - 4

    EP - 8

    JO - Journal of Epidemiology and Community Health

    JF - Journal of Epidemiology and Community Health

    SN - 0143-005X

    IS - 1

    ER -